MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-20-0008959
Alphamed Formulations Private Limited - pharma in Shamirpet, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹196.73 Cr
▲ 22% YoY
Net loss · FY 2025
₹10.65 Cr
Net margin -5.4%
EBITDA · FY 2025
-₹85.31 Lakh
EBITDA margin -0.4%
Authorised capital
₹95 Cr
Registered with MCA
Paid-up capital
₹81.93 Cr
Issued & subscribed
Open charges
₹95 Lakh
Satisfied ₹2.1 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
562
Provident fund records
About Alphamed Formulations Private Limited
Data last updated:
Alphamed Formulations Private Limited is a private limited company based in Shamirpet, Telangana, India, a subsidiary of Apen Pharmacare Holdings Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2006PTC051732. Its GSTIN is 36AAGCA0259A1Z8 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹95 Cr and a paid-up capital of ₹81.93 Cr. It is led by directors including Ramesh Cheruvu (Whole-Time Director) and Chris Mynhard Botha.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. 225 Sampanbole Village Shamirpet Mandal, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹196.73 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net loss of ₹10.65 Cr (net margin -5.4%) and EBITDA of -₹85.31 Lakh (EBITDA margin -0.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 10% over five years.
The company has about 562 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aspen Pharmacare. As per MCA filings, the company has open charges of ₹95 Lakh and satisfied charges of ₹2.1 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 16 deals on record (7 secondary share transfers, 5 funding rounds, 4 rights issues), with disclosed funding of ₹32.39 Cr; the latest was in November 2023. Its 6 peer companies in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Precise Biopharma Private Limited with revenue of ₹200.73 Cr. The company has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 3 overdue payments to 3 micro and small suppliers.
Alphamed Formulations Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0008959). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspenpharma.com.
Company details
CIN U24239TG2006PTC051732
Registration Number 051732
Incorporation Date 20 November 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Apen Pharmacare Holdings Ltd
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0008959
CIN history
Alphamed Formulations has one previous CIN (Corporate Identification Number): U24239AP2006PTC051732. The current CIN is U24239TG2006PTC051732, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2006PTC051732 | Current |
| U24239AP2006PTC051732 | Previous |
Key People
Ramesh Cheruvu Whole-Time Director Chris Mynhard Botha Director Lorraine Angela Hill Director Recognitions & Rankings of Alphamed Formulations
Contact details
Alphamed Formulations Private Limited's registered office is in Shamirpet, Telangana. Its website is aspenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSurvey No. 225 Sampanbole Village Shamirpet Mandal, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Alphamed Formulations Private Limited, buy the company report.
Comprehensive company report
Alphamed Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Alphamed Formulations operates one associated brand: Aspen Pharmacare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Aspen Pharmacare is engaged in manufacturing and distributing pharmaceuticals globally. | aspenpharma.com |
Business activity
The main business activities of Alphamed Formulations are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Alphamed Formulations Private Limited, buy the company report.
Financials of Alphamed Formulations Private Limited
FY 2025 filings availableAlphamed Formulations Private Limited reported revenue of ₹196.73 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹196.73 Cr ▲ 22%
Net loss · FY 2025
₹10.65 Cr margin -5.4%
EBITDA · FY 2025
-₹85.31 Lakh margin -0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 19%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 511%
3 years · compounded
▼ 27%
5 years · compounded
▼ 15%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 22% growth in the latest year. EBITDA fell 511% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹85.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | ||||
| Net Profit Margin | -5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alphamed Formulations Private Limited, buy the company report.
Board of directors of Alphamed Formulations Private Limited
Alphamed Formulations has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Cheruvu | Whole-Time Director | 12 Jun 2018 | 8 Years 4 Months | Current |
| Chris Mynhard Botha | Director | 13 Oct 2023 | 3 Years 0 Months | Current |
| Lorraine Angela Hill | Director | 12 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Alphamed Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Precise Biopharma Private Limited | ₹200.73 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Unique Biotech Limited | ₹198.58 Cr (FY 2024) | 16.0% | Hyderabad, Telangana, India | |||
| Alphamed Formulations Private Limitedthis company | ₹196.73 Cr (FY 2025) | -₹10.65 Cr | -5.4% | 22.0% | 562 | Shamirpet, Telangana, India |
| Oceanic Pharmachem Private Limited | ₹195.72 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Jagdale Industries Private Limited | ₹195.3 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Galentic Pharma India Pvt Ltd | ₹195.24 Cr (FY 2025) | 56.0% | Mumbai, Maharashtra, India | |||
| Therachem Research Medilab (India) Private Limited | ₹194.12 Cr (FY 2023) | -7.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Alphamed Formulations Private Limited, buy the company report.
Shareholding
The shareholding of Alphamed Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alphamed Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹95 Lakh
Satisfied charges
₹2.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2023 | 100795318 | State Bank of India | ₹95 Lakh | Open | |
| 27 Aug 2008 | 10124622 | State Bank of India | ₹9.5 Lakh | Satisfied | |
| 24 Aug 2007 | 10065860 | State Bank of India | ₹2 Cr | Satisfied |
To see the full charge records of Alphamed Formulations Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Alphamed Formulations Private Limited has 16 deals on record (7 secondary share transfers, 5 funding rounds, 4 rights issues), with disclosed funding of ₹32.39 Cr; the latest was in November 2023.
Total deals
16
Secondary share transfers
7
Funding rounds
5
Rights issues
4
Disclosed funding
₹32.39 Cr
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | Rights issue | ₹34.94 Cr | Investors: Aspen Pharmacare Holdings Limited |
| Mar 2022 | Rights issue | ₹98.76 Cr | Investors: Aspen Pharmacare Holdings Limited |
| Feb 2013 | Secondary share transfer | Undisclosed | Buyer: Wisdom Holdings Pte Ltd Seller: Vishar Portfolio Investment Pvt Ltd , 3 individuals |
| Apr 2009 | Funding round | ₹2.71 Cr | Investors: Wisdom Holdings Pte Ltd, Vishar Portfolio Investment Pvt Ltd , 2 individuals |
| Oct 2007 | Funding round | ₹6.89 Cr | Investors: Wisdom Holdings Pte Ltd, 3 individuals |
To see the full deal history of Alphamed Formulations Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Alphamed Formulations Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Appeal | Filed against the company by an individual | Disposed |
| District court, Rangareddy, Telangana | Petition | Filed against the company by an individual | Disposed |
To see the full case history of Alphamed Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Alphamed Formulations Private Limited was last rated by Crisil on 21 Jan 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 21 Jan 2020 |
To see the full credit ratings and regulatory alerts of Alphamed Formulations Private Limited, buy the company report.
MSME payment delays
Alphamed Formulations Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 3 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Electrolab (India) Private Limited | |||
| Ajanta Analytics & Scientific | |||
| Parle Global Technologies Private Limited |
To see the full MSME payment records of Alphamed Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Alphamed Formulations Private Limited has a workforce of 562 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
562
Active EPFO establishments
1
Employee growth
15.16%
GST
Alphamed Formulations has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCA0259A1Z8 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alphamed Formulations Private Limited, buy the company report.
Recent activity
Alphamed Formulations Private Limited has 12 board changes on record since 2013: 3 appointments and 9 cessations. The latest: Sudheer Reddy Gundu ceased to be Company Secretary on 01 Apr 2025.
AGM
Alphamed Formulations Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Ceased
Sudheer Reddy Gundu ceased to be Company Secretary.
Filing
Alphamed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 0.95 Cr registered on 29 Sep 2023 with Charge ID 100795318 was modified on 19 Dec 2024.
Ceased
Chris Mynhard Botha ceased to be Additional Director.
Appointed
Chris Mynhard Botha was appointed as Director.
Charges
A charge registered on 24 Aug 2007 via Charge ID 10065860 with State Bank Of India was fully satisfied on 05 Oct 2023.
Charges
A charge with State Bank Of India amounted to Rs. 0.95 Cr with Charge ID 100795318 was registered on 29 Sep 2023.
Ceased
Rabah Rafa ceased to be Additional Director.
Charges
A charge with State Bank Of India of Rs. 2.00 Cr registered on 24 Aug 2007 with Charge ID 10065860 was modified on 16 Apr 2021.
Charges
A charge registered on 27 Aug 2008 via Charge ID 10124622 with State Bank Of India was fully satisfied on 08 Nov 2019.
Ceased
Bala Murali Krishna Thippabhotla ceased to be Whole-Time Director.
10 earlier events are in the company report.
News
Frequently asked questions
Alphamed Formulations is an active private limited company based in Shamirpet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2006 (20+ years old) and is registered under CIN U24239TG2006PTC051732.
Alphamed Formulations has 3 current directors:
- Ramesh Cheruvu - Whole-Time Director
- Chris Mynhard Botha - Director
- Lorraine Angela Hill - Director
The latest financial statements of Alphamed Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alphamed Formulations is 36AAGCA0259A1Z8, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Alphamed Formulations is U24239TG2006PTC051732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alphamed Formulations has 2 court cases on record: 2 filed against it. Most are in the district courts.
Alphamed Formulations was incorporated on 20 November 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Alphamed Formulations has 16 deals on record (7 secondary share transfers, 5 funding rounds, 4 rights issues), with disclosed funding of ₹32.39 Cr; the latest was in November 2023.
The peers of Alphamed Formulations by revenue are Precise Biopharma Private Limited, Unique Biotech Limited, Oceanic Pharmachem Private Limited, Jagdale Industries Private Limited, Galentic Pharma India Pvt Ltd and 1 more, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sudheer Reddy Gundu ceased to be Company Secretary on 01 Apr 2025. Chris Mynhard Botha ceased to be Additional Director on 26 Sep 2024. Chris Mynhard Botha was appointed as Director on 13 Oct 2023. Alphamed Formulations has 12 board changes on record in total.
Yes, Alphamed Formulations is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0008959).
Alphamed Formulations has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 3 overdue payments to 3 micro and small suppliers. The latest return was filed on 17 Nov 2019.